<p>Basilea Pharmaceutica AG (OTCMKTS:BPMUF - 获取免费报告) 的股价在周一的盘中交易中创下了新的 52 周高点。该公司股价最高达到 72.66 美元，最后交易价格为 72.66 美元，成交量为 11 股。该股票此前收盘价为 72.14 美元。</p>
<p>获取 <strong>Basilea Pharmaceutica</strong> 的提醒：</p>
<h2>Basilea Pharmaceutica 价格表现</h2>
<p>该股票的 50 日移动平均线为 63.99 美元，200 日移动平均线为 64.79 美元。公司的债务与股本比率为 0.79，流动比率为 6.32，速动比率为 5.67。</p>
<h2>关于 Basilea Pharmaceutica</h2>
<p>(获取免费报告)</p>
<p>Basilea Pharmaceutica AG 是一家总部位于瑞士巴塞尔的生物制药公司，专注于医院治疗疾病的创新疗法的开发和商业化。公司的研究主要集中在抗感染和肿瘤学领域，拥有涵盖已上市产品和早期至晚期管道候选药物的产品组合。Basilea 利用药物化学专业知识来解决真菌感染、细菌感染和癌症等关键医疗需求。</p>
<p>其主要产品之一是伊沙伏康唑，这是一种广谱抗真菌药物，商品名为 Cresemba。</p>
<h2>相关文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 Basilea Pharmaceutica</li>
<li>您的签名缺失 - 在为时已晚之前采取行动</li>
<li>什么费用可以从资本利得税中扣除？</li>
<li>用这四个简单步骤让您的银行账户 “防联储”</li>
<li>埃隆是否在为银价震荡做准备？</li>
<li>在周一上午 9:30 购买这只股票！</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资 1,000 美元于 Basilea Pharmaceutica 吗？</h2>
<p>在您考虑 Basilea Pharmaceutica 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Basilea Pharmaceutica 并不在名单上。</p>
<p>虽然 Basilea Pharmaceutica 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Basilea Pharmaceutica (OTCMKTS:BPMUF) 在交易中达到了新的 52 周高点 72.66 美元，成交量为 11 股。该股票的前一交易日收盘价为 72.14 美元，50 日移动平均线为 63.99 美元。该公司专注于生物制药，主要研究抗感染药物和肿瘤学。尽管股票表现良好，分析师目前将其评级为持有，暗示可能存在更好的投资机会</p>

<p>Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $72.66 and last traded at $72.66, with a volume of 11 shares traded. The stock had previously closed at $72.14.</p>
<div class="lb-trans"><p>Basilea Pharmaceutica AG (OTCMKTS:BPMUF - 获取免费报告) 的股价在周一的盘中交易中创下了新的 52 周高点。该公司股价最高达到 72.66 美元，最后交易价格为 72.66 美元，成交量为 11 股。该股票此前收盘价为 72.14 美元。</p>
</div><p>Get <strong>Basilea Pharmaceutica</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Basilea Pharmaceutica</strong> 的提醒：</p>
</div><h2>Basilea Pharmaceutica Price Performance</h2>
<div class="lb-trans"><h2>Basilea Pharmaceutica 价格表现</h2>
</div><p>The stock has a 50-day moving average of $63.99 and a two-hundred day moving average of $64.79. The company has a debt-to-equity ratio of 0.79, a current ratio of 6.32 and a quick ratio of 5.67.</p>
<div class="lb-trans"><p>该股票的 50 日移动平均线为 63.99 美元，200 日移动平均线为 64.79 美元。公司的债务与股本比率为 0.79，流动比率为 6.32，速动比率为 5.67。</p>
</div><h2>About Basilea Pharmaceutica</h2>
<div class="lb-trans"><h2>关于 Basilea Pharmaceutica</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Basilea Pharmaceutica AG is a Swiss biopharmaceutical company headquartered in Basel, specializing in the development and commercialization of innovative treatments for hospital‐treated diseases. The company's research is focused primarily on anti‐infectives and oncology, with a portfolio that spans both marketed products and early‐ to late‐stage pipeline candidates. Basilea leverages medicinal chemistry expertise to address critical medical needs in fungal infections, bacterial infections and cancer.</p>
<div class="lb-trans"><p>Basilea Pharmaceutica AG 是一家总部位于瑞士巴塞尔的生物制药公司，专注于医院治疗疾病的创新疗法的开发和商业化。公司的研究主要集中在抗感染和肿瘤学领域，拥有涵盖已上市产品和早期至晚期管道候选药物的产品组合。Basilea 利用药物化学专业知识来解决真菌感染、细菌感染和癌症等关键医疗需求。</p>
</div><p>Among its lead products is isavuconazole, a broad‐spectrum antifungal agent marketed under the trade name Cresemba.</p>
<div class="lb-trans"><p>其主要产品之一是伊沙伏康唑，这是一种广谱抗真菌药物，商品名为 Cresemba。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>相关文章</h2>
</div><ul>
<li>Five stocks we like better than Basilea Pharmaceutica</li>
<li>Your Signature Is Missing – Act Before It’s Too Late</li>
<li>What Expenses Can Be Deducted From Capital Gains Tax?</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
<li>Is Elon Preparing for a Silver Shock?</li>
<li>Buy This Stock at 9:30 AM on MONDAY!</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Basilea Pharmaceutica</li>
<li>您的签名缺失 - 在为时已晚之前采取行动</li>
<li>什么费用可以从资本利得税中扣除？</li>
<li>用这四个简单步骤让您的银行账户 “防联储”</li>
<li>埃隆是否在为银价震荡做准备？</li>
<li>在周一上午 9:30 购买这只股票！</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Basilea Pharmaceutica Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元于 Basilea Pharmaceutica 吗？</h2>
</div><p>Before you consider Basilea Pharmaceutica, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Basilea Pharmaceutica 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Basilea Pharmaceutica wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Basilea Pharmaceutica 并不在名单上。</p>
</div><p>While Basilea Pharmaceutica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Basilea Pharmaceutica 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Basilea Pharmaceutica (OTCMKTS:BPMUF) 创下 52 周新高 - 你是否应该购买？